City of Hope, an NCI-designated comprehensive cancer center in Duarte, California, has announced a $100 million gift from its longtime research director, Arthur Riggs, in support of cancer and diabetes research.
Riggs, the Samuel Rahbar Chair in Diabetes & Drug Discovery and director emeritus of the Beckman Research Institute at City of Hope, helped develop the technology used to create synthetic human insulin as well as recombinant DNA technology for producing humanized monoclonal antibodies used in treatments for diabetes, cancer, autoimmune diseases, blindness, and other diseases.
Over the past thirty years, Riggs has quietly donated nearly all the wealth generated by his scientific discoveries in support of efforts to develop new treatments for disease. In recognition of his support, which now totals $310 million, City of Hope will rename its diabetes research center the Arthur Riggs Diabetes & Metabolism Research Institute.
According to City of Hope, Riggs, who had always insisted that his gifts remain anonymous, is making his philanthropy public now in the hope of encouraging other donors to join the organization's fight against diabetes and cancer.
"I came to City of Hope because the environment here offers exactly that — hope for people with diabetes, cancer, and many other serious diseases," said Riggs. "I believe in the promise of our work at City of Hope so strongly that one day, probably sooner than most think, we'll create a world without diabetes. Yet we will realize the full potential of this important work only through the generosity of many other donors who will choose to join us."
(Photo credit: City of Hope)